1. Technical Field
The present disclosure relates to biomedical electrodes, and in particular, to a radiolucent biomedical electrode connector and radiolucent lead wires for performing biomedical monitoring of a patent during imaging procedures.
2. Background of Related Art
Electrocardiograph (ECG) monitors are widely used to obtain medical (i.e., biopotential) signals containing information indicative of the electrical activity associated with the heart and pulmonary system. To obtain medical signals, ECG electrodes are applied to the skin of a patient in various locations. The electrodes, after being positioned on the patient, connect to an ECG monitor by a set of ECG lead wires. The distal end of the ECG lead wire, or portion closest to the patient, may include a connector which is adapted to operably connect to the electrode to receive medical signals from the body. The proximal end of the ECG lead set is operably coupled to the ECG monitor either directly or indirectly through an adapter, and supplies the medical signals received from the body to the ECG monitor.
A typical ECG electrode assembly may include an electrically conductive layer and a backing layer, the assembly having a patient contact side and a connector side. The contact side of the electrode pad may include biocompatible conductive gel or adhesive for affixing the electrode to a patient's body for facilitating an appropriate electrical connection between a patient's body and the electrode assembly. The connector side of the pad may incorporate a metallic press stud having a bulbous profile for coupling the electrode pad to the ECG lead wire. In use, the clinician removes a protective covering from the electrode side to expose the gel or adhesive, affixes the electrode pad to the patient's body, and attaches the appropriate ECG lead wire connector to the press stud by pressing or “snapping” the lead wire connector onto the bulbous press stud to achieve mechanical and electrical coupling of the electrode and lead wire. Alternatively, ECG connectors that engage via manipulation of a lever or other mechanical locking device may be employed. After use, a clinician then removes the ECG lead wire connector from the pad by pulling or “unsnapping” the connector from the pad or by releasing the lever or other locking mechanism.
Placement of the electrodes on a patient has been established by medical protocols. A common protocol requires the placement of the electrodes in a 5-lead configuration: one electrode adjacent each clavicle bone on the upper chest and a third electrode adjacent the patient's lower left abdomen, a fourth electrode adjacent the sternum, and a fifth electrode on the patient's lower right abdomen.
During certain procedures it may be necessary to monitor biological (e.g., ECG) parameters of a patient that is undergoing imaging, such as CT-scan or MRI. Use of conventional ECG connectors and lead wire sets typically associated therewith may have drawbacks in these applications, since they tend to interfere with the imaging systems. In one example, certain components of the ECG connectors and/or lead wires may be detected by the imaging apparatus and consequently may obfuscate the visual images upon which clinicians and surgeons rely. In another example, ferrous and/or magnetic components commonly found in ECG connectors, such as in springs and clips, may be potentially hazardous when used within the intense magnetic field of an MRI scanner.
In an embodiment in accordance with the present disclosure, there is provided an ECG lead system that, in accordance with embodiments of the present disclosure, comprises a radiolucent ECG lead set assembly and an ECG lead extension assembly. The ECG lead set assembly comprises a radiolucent ECG lead set cable having at least one radiolucent conductor. At least one radiolucent electrode connector is operatively coupled to a distal end of the ECG lead set cable, and an ECG intermediate lead set connector is disposed at a proximal end of the ECG lead set cable. The ECG lead extension assembly comprises an ECG lead extension cable having at least one conductor. An ECG lead set extension connector is disposed at a distal end of the ECG lead extension cable, and a device connector is disposed at a proximal end of the ECG lead extension cable. The ECG intermediate lead set connector is configured to operatively couple to the ECG lead set extension connector. The device connector is configured to operatively couple to an ECG monitor.
A method of performing an ECG on a patient undergoing an imaging procedure is provided. In embodiments according to the present disclosure, the method comprises providing one or more radiolucent ECG connectors as described herein, providing a radiolucent ECG lead system as described herein, attaching one or more electrode pads to the body of a patient, operatively coupling the one or more radiolucent ECG connectors to a corresponding one of the one or more electrode pads, operatively coupling the device connector to an ECG monitor, and imaging the patient in an imaging apparatus selected from the group consisting of an MRI scanner, a CT scanner, and a PET scanner. The method in may include coupling the ECG intermediate lead set connector to the ECG lead set extension connector. Additionally or alternatively, the method may include providing an adapter configured to enable operable coupling of the device connector to an ECG monitor, coupling the device connector to the adapter, and coupling the adapter to the ECG monitor.
In another aspect, an ECG connector assembly in accordance with the present disclosure includes a housing having an opening defined therein configured to operably receive an electrode post of an ECG electrode pad. The ECG connector assembly includes an electrode member having a generally semicircular contact face and is disposed along at least a part of the perimeter of the opening. The ECG connector assembly includes an engagement member having an actuation surface and an engaging face. The engagement member is pivotable about a pivot to enable the engaging face to move from a first position whereby the engaging face is closer to the contact face and a second position whereby the engaging face is further from the contact face. A resilient radiused member joins a finger to a proximal end of the engagement member and is configured to bias the engagement member towards the first position. The ECG connector assembly includes a leadwire configured to operatively couple the electrode member to an ECG monitor.
In some embodiments, at least one of the electrode member or the leadwire is formed from radiolucent material. In some embodiments, the electrode member includes a junction block configured to facilitate operational coupling with the leadwire conductor. In some embodiments, the housing includes a retaining rib defining a cavity configured to retain the electrode member to the housing. In some embodiments, the actuating surface may include one or more ergonomic features, such as without limitation one or more scallops, one or more ridges, one or more grooves, knurling, contouring, a friction-enhancing surface, an elastomeric coating, an elastomeric grip, or a textured grip. In some embodiments, the ECG connector includes a bulkhead provided by the housing wherein the finger slidably engages the bulkhead when the engagement member moves between the first position and the second position. In some embodiments, the ECG connector assembly includes a channel configured to support a leadwire. The channel may includes an s-shaped strain relief portion configured to resist pullout of the leadwire. The ECG connector assembly may include a cover wherein at least a portion of the perimeter thereof includes a mating ridge, and a side wall extending from at least a portion of the perimeter of the housing and having a mating groove defined along a top surface thereof that is configured to engage the mating ridge of the cover. In some embodiments, the ECG connector assembly includes a female feature defined in the housing that is configured to receive a corresponding male projection, and a male projection extending from the cover that is configured to operably engage the female feature.
Various embodiments of the present disclosure are described hereinbelow with references to the drawings, wherein:
Particular embodiments of the present disclosure are described hereinbelow with reference to the accompanying drawings; however, the disclosed embodiments are merely examples of the disclosure, which may be embodied in various forms. Well-known functions or constructions and repetitive matter are not described in detail to avoid obscuring the present disclosure in unnecessary or redundant detail. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present disclosure in virtually any appropriately detailed structure. In this description, as well as in the drawings, like-referenced numbers represent elements which may perform the same, similar, or equivalent functions.
In the drawings and in the descriptions that follow, the term “proximal,” as is traditional, shall refer to the end of the instrument that is closer to a user, while the term “distal” shall refer to the end that is farther from a user. In addition, as used herein, terms referencing orientation, e.g., “top”, “bottom”, “up”, “down”, “left”, “right”, “clockwise”, “counterclockwise”, and the like, are used for illustrative purposes with reference to the figures and features shown therein. Embodiments in accordance with the present disclosure may be practiced in any orientation without limitation.
The present invention is directed to an electrode system suitable for use during patient imaging, such as during a CT-scan or MRI. Commonly available electrode connectors have components which may be detected on the image and/or may become dangerous when exposed to a particular field, such as a magnetic field.
Accordingly, one aspect of the present invention provides an electrode connector which may be used during patient imaging. One embodiment of an ECG electrode connector of the present invention is shown in
ECG electrode connector 1400 is configured to facilitate the monitoring of ECG and other biological parameters while the subject patient is undergoing an imaging procedure, such as without limitation, MRI, CT, PET, and the like. Connector 1400 includes a housing 1424 having an interior recessed surface 1431 that includes an opening 1434 defined therein that opens to a patient-facing surface of the housing. Opening 1434 is dimensioned to accept the insertion of a head of a press stud of a patient electrode. Housing 1424 may be formed from any suitable non-conductive material, including polymeric materials. The connector 1400 includes an engagement member 1436 having an actuation surface 1439, which may be a contoured pushbutton, and an engaging face 1437. Engagement member 1436 is pivotable about a pivot 1415 to enable the engaging face 1437 to move from a first position whereby engaging face 1437 is disposed closer to a top portion 1425 of opening 1434 and a second position whereby engaging face 1437 is disposed further from a top portion 1425 of opening 1434. By this arrangement, the bulbous head of a press stud that has been introduced into opening 1434 may be captured in opening 1434 between engaging face 1437 and a sidewall of opening 1434. Engagement member 1436 includes a stiffener 1438, that may have an arcuate shape, disposed between engaging face 1437 and pivot 1415.
The interior recessed surface 1431 of housing 1424 includes a radiolucent conductor 1432 that facilitates the conduction of biological signals between a press stud captured within opening 1434 and a lead wire conductor 1477. Radiolucent conductor 1432 may be included within surface 1431 by any suitable manner, including without limitation, as a conductive coating and/or a conductive material incorporated within housing 1424 or associated portions thereof. In some embodiments, radiolucent conductor 1432 may be formed by dispersing conductive carbon powder over interior recessed surface 1431. The conductive carbon powder is then fused via the application of heat and/or pressure to the polymeric material that forms interior recessed surface 1431. In some embodiments, radiolucent conductor 1432 may be formed by the application of radiolucent conductive ink to interior recessed surface 1431. In other embodiments, the radiolucent conductor 1432 may comprise a carbon fiber wire fixed to the recessed surface 1431. As shown in
ECG electrode connector 1400 includes a lead wire 1475 extending from a proximal (e.g., bottom) end thereof. Lead wire 1475 includes an outer insulator 1476 coaxially disposed about a conductor 1477. Conductor 1477 is formed from radiolucent electrically conductive material, such as conductive carbon or conductive carbon monofilament wire. In some embodiments, conductor 1477 is formed from one or more carbon fibers. A distal portion of the outer insulator is stripped thus exposing a distal portion of conductor 1477′. The exposed portion 1477′ of conductor 1477 is operatively joined to radiolucent conductor 1432 of interior recessed surface 1431. Conductor 1477′ may be joined by any suitable manner, including without limitation by a crimping element 1478 and/or by radiolucent electrically conductive adhesive. In some embodiments, the exposed portion 1477′ of conductor 1477 and radiolucent conductor 1432 are integrally formed. A strain relief 1479 surrounds a portion of lead wire 1475 where lead wire 1475 exits the housing 1424.
A resilient member 1470 biases engagement member 1436 towards a first position whereby engaging face 1437 is closer to a top portion 1425 of opening 1434. Lobed resilient member 1470 is positioned between a recess 1428 defined in engagement member 1436 and a saddle 1472 provided by housing 1424. Resilient member 1470 may be formed from a radiolucent elastomer, including without limitation, silicone. Resilient member 1470 may have any shape to provide sufficient force to allow the desired movement of the engagement member 1436. The resilient member 1470 may have any regular or irregular shape, including circle, square, triangle, and clover.
In some embodiments, resilient member 1470 is a lobed member. In the embodiment shown in
During use, a user may apply force to actuating surface 1439 using, e.g., a fingertip, thereby overcoming the biasing force of resilient member 1470 to cause engagement member 1436 to rotate slightly counterclockwise about pivot 1415. In turn, engaging face 1437 moves further from a top surface 1425 of opening 1434 which provides sufficient clearance to enable the introduction of a bulbous head of a press stud into opening 1434. Once the press stud is inserted into opening 1434, the user may remove finger pressure from actuating surface 1439, whereupon the biasing force of resilient member 1470 causes engagement member 1436 to rotate slightly clockwise about pivot 1415, thereby electromechanically engaging the press stud with a portion of opening 1434 and thus, electrically coupling the press stud with radiolucent conductor 1432 and conductor 1477.
Yet another embodiment of a radiolucent ECG electrode connector is shown in
ECG electrode connector 1500 includes a lead wire 1575 extending from a proximal (e.g., bottom) end thereof. Lead wire 1575 includes an outer insulator 1576 coaxially disposed about a conductor 1477. Conductor 1477 is formed from radiolucent electrically conductive material, such as conductive carbon or conductive carbon monofilament wire. In some embodiments, conductor 1577 is formed from one or more carbon fibers. A distal portion of the outer insulator is stripped thus exposing a distal portion of conductor 1577′. The exposed portion 1577′ of conductor 1577 is operatively joined to radiolucent conductor 1532 of interior recessed surface 1531. Conductor 1577′ may be joined by any suitable manner, including without limitation by a crimping element 1578 and/or by radiolucent electrically conductive adhesive. In some embodiments, the exposed portion 1577′ of conductor 1577 and radiolucent conductor 1532 are integrally formed. A strain relief 1579 surrounds a portion of lead wire 1575 where lead wire 1575 exits the housing 1524.
A resilient member 1570 biases engagement member 1536 towards a first position whereby engaging face 1537 is closer to a top portion 1525 of opening 1534. Resilient member 1570 may have any shape to provide sufficient force to allow the desired movement of the engagement member 1536. The resilient member 1570 may have any regular or irregular shape, including circle, square, triangle, ellipsoidal, and clover, and may, but need not be, solid throughout. In some embodiments resilient member 1570 has a generally spherical shape. Resilient member 1570 is positioned between a recess 1528 defined in engagement member 1536 and a saddle 1572 provided by a housing 1524. Resilient member 1570 may be formed from a radiolucent elastomer, including without limitation, silicone. In the embodiment shown in
Turning now to
The radiolucent ECG lead set cables 1602 include a center conductor 1614 and an outer insulator 1612. Center conductor 1614 is formed from a radiolucent electrically conductive material, including without limitation one or more carbon fibers. The one or more carbon fibers may be combined with other materials, including without limitation, polypropylene, polycarbonate, polyethylene, polyurethane, or polytetrafluoroethylene fibers to increase strength and/or flexibility of the conductor and the overall cable assembly 1620.
The ECG lead system 1600 further includes an ECG lead extension assembly 1630. ECG lead extension assembly 1630 includes an ECG lead extension cable 1606, which may be configured as a ribbon cable as shown in
An ECG lead set extension connector 1605 is disposed at a distal end of the ECG lead extension cable 1630. ECG lead set extension connector 1605 is configured and adapted to mate with and electrically connect to the intermediate lead set connector 1604 that is disposed at a proximal end of the ECG lead set cable 1620.
A device connector 1607 disposed at a proximal end of the ECG lead extension cable 1630. Device connector 1607 is configured and adapted to mate with and electrically connect to an ECG monitor 1610.
Additionally or alternatively, an adapter 1608 may be configured and adapted to mate with, and operably couple to, device connector 1607. Adapter 1608 is configured to enable operable coupling or interfacing between device connector 1607 and an ECG monitor 1610 that would otherwise be incompatible with the electrical or physical configuration of device connector 1607.
In use, as seen in
With reference now to
Housing 1805 includes an electrode member 1820 having a generally semicircular contact face 1821 that is disposed along at least a part of the perimeter of opening 1834. In some embodiments, contact face 1821 may have any size and shape, provided that at least a portion thereof extends into opening 1834 along at least a portion of the perimeter thereof. In some embodiments, contact face 1821 extends through opening 1834 to completely cover at least a portion of the circumference of the opening 1834. Electrode member 1820 and/or contact face 1821 may be formed from a radiolucent conductive material such as, without limitation, conductive polymer, conductive elastomeric material, conductive carbon, and/or carbon-impregnated substrate.
Electrode member 1820 includes a junction block 1878 that is configured to facilitate operational coupling (e.g., electrical, mechanical, electromechanical) with a leadwire conductor 1877. Advantangeously, junction block 1878 may be formed from radiolucent material (e.g., conductive carbon). Electrode member 1820 and leadwire conductor 1877 may be joined using any suitable manner of connection, including without limitation, crimping, welding, brazing, overmolding, conductive adhesive.
In some embodiments, electrode member 1820 and leadwire conductor 1877 may be integrally formed. Housing 1805 includes at least one retaining rib 1806 that may provide additional support to electrode member 1820. In some embodiments, such as without limitation, those embodiments where electrode member 1820 is formed by overmolding, the at least one retaining rib 1806 defines a cavity into which overmolding material is deposited during the manufacturing process, which, in turn, reduces the complexity of molds and forms required to produce ECG electrode connector 1800.
A leadwire 1875 is received by housing 1805 via a strain relief 1879. Leadwire 1875 includes leadwire conductor 1877 coaxially disposed within a leadwire outer insulator 1876 (e.g., an insulating jacket). As best seen in
ECG electrode connector 1800 includes an engagement member 1836 having an actuation surface 1839 and an engaging face 1837. As shown in
A finger 1841 is joined to a proximal end of engagement member 1836 by a generally u-shaped resilient radiused member 1840. In some embodiments, engagement member 1836, resilient radiused member 1840, and/or finger 1841 are integrally formed. Engagement member 1836, resilient radiused member 1840, and finger 1841 are arranged to enable tip 1843 of finger 1841 to ride along bulkhead 1842 and thereby bias engagement member 1836 towards a first position whereby engaging face 1837 is closer to contact face 1821. Resilient radiused member 1840 may have any suitable shape, such as without limitation a u-shape as depicted in
It will be understood that various modifications may be made to the embodiments disclosed herein. Further variations of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems, instruments and applications. Various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art, which are also intended to be encompassed by the following claims.
This application is a continuation of U.S. patent application Ser. No. 13/987,326, filed 15 Mar. 2013, entitled RADIOLUCENT ECG ELECTRODE SYSTEM, the entire disclosure of which is hereby incorporated by reference for all intents and purposes.
Number | Name | Date | Kind |
---|---|---|---|
3606881 | Woodson | Sep 1971 | A |
3701218 | Priest | Oct 1972 | A |
3752151 | Robichaud | Aug 1973 | A |
3805769 | Sessions | Apr 1974 | A |
3828766 | Krasnow | Aug 1974 | A |
3829826 | Brown et al. | Aug 1974 | A |
3842394 | Bolduc | Oct 1974 | A |
3868946 | Hurley | Mar 1975 | A |
3888240 | Reinhold, Jr. et al. | Jun 1975 | A |
3895635 | Justus et al. | Jul 1975 | A |
3901218 | Buchalter | Aug 1975 | A |
3997225 | Horwinski | Dec 1976 | A |
3998213 | Price | Dec 1976 | A |
4027664 | Heavner, Jr. et al. | Jun 1977 | A |
4034854 | Bevilacqua | Jul 1977 | A |
4077397 | Ellis et al. | Mar 1978 | A |
4112941 | Larimore | Sep 1978 | A |
4144889 | Tyers et al. | Mar 1979 | A |
4166465 | Esty et al. | Sep 1979 | A |
4220390 | Cobaugh et al. | Sep 1980 | A |
4303293 | Grunwald | Dec 1981 | A |
D263167 | Stone | Feb 1982 | S |
4353372 | Ayer | Oct 1982 | A |
4365634 | Bare et al. | Dec 1982 | A |
4374448 | Loffler | Feb 1983 | A |
4498480 | Mortensen | Feb 1985 | A |
4674817 | Olms | Jun 1987 | A |
4729377 | Granek et al. | Mar 1988 | A |
4763660 | Kroll et al. | Aug 1988 | A |
4781200 | Baker | Nov 1988 | A |
4785822 | Wallace | Nov 1988 | A |
4797125 | Malana | Jan 1989 | A |
4815964 | Cohen et al. | Mar 1989 | A |
4842557 | Muz | Jun 1989 | A |
4850356 | Heath | Jul 1989 | A |
4909260 | Salem et al. | Mar 1990 | A |
4911657 | Berlin | Mar 1990 | A |
4947846 | Kitagawn et al. | Aug 1990 | A |
4957109 | Groeger et al. | Sep 1990 | A |
4974594 | Berlin | Dec 1990 | A |
5062426 | Ulbrich et al. | Nov 1991 | A |
5080604 | Rider et al. | Jan 1992 | A |
5083238 | Bousman | Jan 1992 | A |
5083933 | Colleran et al. | Jan 1992 | A |
5104253 | Zielinski et al. | Apr 1992 | A |
5104334 | Honma et al. | Apr 1992 | A |
5131854 | Jose et al. | Jul 1992 | A |
5137466 | Endo et al. | Aug 1992 | A |
5154646 | Shoup | Oct 1992 | A |
5158469 | Martin | Oct 1992 | A |
5160276 | Marsh et al. | Nov 1992 | A |
5173059 | Sato et al. | Dec 1992 | A |
5176343 | Cheney et al. | Jan 1993 | A |
5178556 | Chen | Jan 1993 | A |
5180312 | Martin | Jan 1993 | A |
5190467 | Ohta | Mar 1993 | A |
5192226 | Wang | Mar 1993 | A |
5197901 | Hashiguchi | Mar 1993 | A |
5199897 | Hashiguchi | Apr 1993 | A |
5201669 | Lin | Apr 1993 | A |
5203715 | Yamamoto | Apr 1993 | A |
5203719 | Kozono | Apr 1993 | A |
5207594 | Olson | May 1993 | A |
5209679 | Quinlan | May 1993 | A |
5224479 | Sekine | Jul 1993 | A |
5232383 | Barnick | Aug 1993 | A |
5234357 | Yamaguchi | Aug 1993 | A |
5243510 | Cheney | Sep 1993 | A |
5263481 | Axelgaard | Nov 1993 | A |
5276443 | Gates et al. | Jan 1994 | A |
5278759 | Berra et al. | Jan 1994 | A |
5279308 | DiSabito et al. | Jan 1994 | A |
5293013 | Takahashi | Mar 1994 | A |
5320621 | Gordon et al. | Jun 1994 | A |
5326272 | Harhen et al. | Jul 1994 | A |
5332330 | Kaneko | Jul 1994 | A |
5338219 | Hiramoto | Aug 1994 | A |
5341806 | Gadsby et al. | Aug 1994 | A |
5341812 | Allaire et al. | Aug 1994 | A |
5353793 | Bornn | Oct 1994 | A |
5354216 | Cruise et al. | Oct 1994 | A |
5362249 | Carter | Nov 1994 | A |
5370116 | Rollman et al. | Dec 1994 | A |
5370550 | Alwine et al. | Dec 1994 | A |
5376016 | Inaba et al. | Dec 1994 | A |
5378168 | Sumida | Jan 1995 | A |
5380223 | Marsh et al. | Jan 1995 | A |
5382176 | Norden | Jan 1995 | A |
5383794 | Davis et al. | Jan 1995 | A |
5387116 | Wang | Feb 1995 | A |
5387127 | Wang | Feb 1995 | A |
5399045 | Yoneda et al. | Mar 1995 | A |
5403353 | Alferness et al. | Apr 1995 | A |
5405269 | Stupecky | Apr 1995 | A |
5407368 | Stand et al. | Apr 1995 | A |
5415164 | Faupel et al. | May 1995 | A |
5429526 | Ann | Jul 1995 | A |
5431166 | Macur | Jul 1995 | A |
5454739 | Strand | Oct 1995 | A |
5462448 | Kida et al. | Oct 1995 | A |
5484739 | Lee et al. | Jan 1996 | A |
5486117 | Chang | Jan 1996 | A |
5507290 | Kelly et al. | Apr 1996 | A |
5507665 | Oda | Apr 1996 | A |
5507668 | Lambrinos et al. | Apr 1996 | A |
5509822 | Negus et al. | Apr 1996 | A |
5511553 | Segalowitz | Apr 1996 | A |
5546950 | Schoeckert et al. | Aug 1996 | A |
5558535 | Saka et al. | Sep 1996 | A |
5564939 | Maitani et al. | Oct 1996 | A |
5582180 | Manset et al. | Dec 1996 | A |
5584719 | Tsuji et al. | Dec 1996 | A |
D377219 | Strand et al. | Jan 1997 | S |
5599199 | Wright | Feb 1997 | A |
5603632 | Johannes et al. | Feb 1997 | A |
5611708 | Mizunuma et al. | Mar 1997 | A |
5613870 | Traver, Jr. | Mar 1997 | A |
5615674 | Maurer | Apr 1997 | A |
5615874 | Parthasarathy et al. | Apr 1997 | A |
5622168 | Keusch et al. | Apr 1997 | A |
5624271 | Childs et al. | Apr 1997 | A |
5624281 | Christensson | Apr 1997 | A |
5626135 | Sanfilippo | May 1997 | A |
5632274 | Quedens et al. | May 1997 | A |
5651689 | Plyler et al. | Jul 1997 | A |
5653606 | Chrysostomou | Aug 1997 | A |
5674088 | Roche et al. | Oct 1997 | A |
5676694 | Boser et al. | Oct 1997 | A |
5679022 | Cappa et al. | Oct 1997 | A |
5679029 | Saunier et al. | Oct 1997 | A |
5685303 | Rollman et al. | Nov 1997 | A |
5695355 | Hasenfratz et al. | Dec 1997 | A |
5702265 | Yamaguchi | Dec 1997 | A |
5704351 | Mortara et al. | Jan 1998 | A |
5711684 | Inoue et al. | Jan 1998 | A |
5718596 | Inaba et al. | Feb 1998 | A |
5724025 | Tavori | Mar 1998 | A |
5724984 | Arnold et al. | Mar 1998 | A |
5725525 | Kordis | Mar 1998 | A |
5741155 | Herman | Apr 1998 | A |
5749746 | Tan et al. | May 1998 | A |
5769650 | Aoyama et al. | Jun 1998 | A |
5772591 | Cram | Jun 1998 | A |
5775953 | Yamanashi et al. | Jul 1998 | A |
5782647 | Okura et al. | Jul 1998 | A |
5782761 | Gusakov | Jul 1998 | A |
5782892 | Castle et al. | Jul 1998 | A |
5788527 | Sanders et al. | Aug 1998 | A |
5791918 | Pierce | Aug 1998 | A |
5797854 | Hedgecock | Aug 1998 | A |
5806152 | Saitou et al. | Sep 1998 | A |
5810806 | Ritchart et al. | Sep 1998 | A |
5813404 | Devlin et al. | Sep 1998 | A |
5813979 | Wolfer | Sep 1998 | A |
5827086 | Fukuda | Oct 1998 | A |
5830000 | Shifflett et al. | Nov 1998 | A |
5836783 | Morisawa et al. | Nov 1998 | A |
5843141 | Bischoff et al. | Dec 1998 | A |
5848450 | Oexman et al. | Dec 1998 | A |
5848456 | Sjoqvist | Dec 1998 | A |
5865740 | Kelly et al. | Feb 1999 | A |
5865741 | Kelly et al. | Feb 1999 | A |
5871451 | Unger et al. | Feb 1999 | A |
5873747 | Tsuji | Feb 1999 | A |
5876232 | Matsushita et al. | Mar 1999 | A |
5895284 | Kocher et al. | Apr 1999 | A |
5895298 | Faupel | Apr 1999 | A |
5904579 | Mclean et al. | May 1999 | A |
5913834 | Francais | Jun 1999 | A |
5916159 | Kelly et al. | Jun 1999 | A |
5931689 | Patel | Aug 1999 | A |
5931861 | Werner et al. | Aug 1999 | A |
5934926 | Gabrisko, Jr. et al. | Aug 1999 | A |
5937950 | Adams et al. | Aug 1999 | A |
5938470 | Kashiyama | Aug 1999 | A |
5938597 | Starbucker | Aug 1999 | A |
5941725 | Brennan et al. | Aug 1999 | A |
5944562 | Christensson | Aug 1999 | A |
5951316 | Kawano et al. | Sep 1999 | A |
5964624 | Pernelle | Oct 1999 | A |
5968087 | Hess et al. | Oct 1999 | A |
5971790 | Rohde | Oct 1999 | A |
5971799 | Swade | Oct 1999 | A |
5980332 | Tsuji et al. | Nov 1999 | A |
5984717 | Lee | Nov 1999 | A |
5997334 | Goto | Dec 1999 | A |
6006125 | Kelly et al. | Dec 1999 | A |
6023354 | Goldstein et al. | Feb 2000 | A |
6027359 | Aoki et al. | Feb 2000 | A |
6032063 | Hoar et al. | Feb 2000 | A |
6032064 | Devlin et al. | Feb 2000 | A |
6038479 | Werner et al. | Mar 2000 | A |
6038481 | Werner et al. | Mar 2000 | A |
6050838 | Norizuki et al. | Apr 2000 | A |
6055448 | Anderson et al. | Apr 2000 | A |
6062902 | Buckles et al. | May 2000 | A |
6066093 | Kelly et al. | May 2000 | A |
6074234 | Hasegawa | Jun 2000 | A |
6098127 | Kwang | Aug 2000 | A |
6109948 | Kuo | Aug 2000 | A |
6115623 | McFee | Sep 2000 | A |
6116940 | Bertens et al. | Sep 2000 | A |
6122536 | Sun et al. | Sep 2000 | A |
6122544 | Organ | Sep 2000 | A |
6129666 | Deluca et al. | Oct 2000 | A |
6132233 | Fukuda | Oct 2000 | A |
6139350 | Mathesius | Oct 2000 | A |
6139360 | Hayashi | Oct 2000 | A |
6152778 | Dalton | Nov 2000 | A |
6155864 | Yoshiura | Dec 2000 | A |
6157851 | Kelly et al. | Dec 2000 | A |
6165017 | Kuo | Dec 2000 | A |
6168453 | Kuo | Jan 2001 | B1 |
6171139 | Sato et al. | Jan 2001 | B1 |
6190385 | Tom et al. | Feb 2001 | B1 |
6203354 | Kuwahara | Mar 2001 | B1 |
6219568 | Kelly et al. | Apr 2001 | B1 |
6219569 | Kelly et al. | Apr 2001 | B1 |
6223088 | Scharnberg et al. | Apr 2001 | B1 |
6232366 | Wang et al. | May 2001 | B1 |
6234827 | Nishio et al. | May 2001 | B1 |
6236874 | Devlin et al. | May 2001 | B1 |
6240323 | Calenzo, Sr. et al. | May 2001 | B1 |
6247963 | Rattner | Jun 2001 | B1 |
6250955 | Archuleta | Jun 2001 | B1 |
6254425 | Shchervinsky | Jul 2001 | B1 |
6257914 | Comerci et al. | Jul 2001 | B1 |
6257925 | Jones | Jul 2001 | B1 |
6280209 | Bassler et al. | Aug 2001 | B1 |
6280227 | Terada et al. | Aug 2001 | B1 |
6280243 | Liu et al. | Aug 2001 | B1 |
6283789 | Tsai | Sep 2001 | B1 |
6290530 | Chang | Sep 2001 | B1 |
6298255 | Cordero et al. | Oct 2001 | B1 |
6304783 | Lyster et al. | Oct 2001 | B1 |
6312297 | Lorkowski | Nov 2001 | B1 |
6324432 | Rigaux et al. | Nov 2001 | B1 |
D452318 | Merry et al. | Dec 2001 | S |
6334798 | Ushijima | Jan 2002 | B1 |
6339720 | Anzellini et al. | Jan 2002 | B1 |
6340306 | Daoud | Jan 2002 | B1 |
6356779 | Katzenmaier et al. | Mar 2002 | B1 |
6358083 | Kraft | Mar 2002 | B1 |
6360119 | Roberts | Mar 2002 | B1 |
6363272 | Combs | Mar 2002 | B1 |
6364685 | Manning | Apr 2002 | B1 |
6383010 | Mayo et al. | May 2002 | B1 |
6383011 | Chen | May 2002 | B2 |
6383036 | Steinhauser et al. | May 2002 | B1 |
6386917 | Sakaguchi | May 2002 | B1 |
6393317 | Fukuda et al. | May 2002 | B1 |
6394953 | Devlin et al. | May 2002 | B1 |
6398557 | Hoballah | Jun 2002 | B1 |
6398575 | Bresson | Jun 2002 | B1 |
6398577 | Simmel et al. | Jun 2002 | B1 |
6400977 | Kelly et al. | Jun 2002 | B1 |
6411516 | Palumbo et al. | Jun 2002 | B1 |
6411834 | Nagai | Jun 2002 | B1 |
6413112 | Semmeling et al. | Jul 2002 | B2 |
6415169 | Kornrumpf et al. | Jul 2002 | B1 |
6419636 | Young et al. | Jul 2002 | B1 |
6434410 | Cordero et al. | Aug 2002 | B1 |
6445955 | Michelson et al. | Sep 2002 | B1 |
6447170 | Takahashi et al. | Sep 2002 | B1 |
6453186 | Lovejoy et al. | Sep 2002 | B1 |
6454577 | Yi | Sep 2002 | B1 |
6454590 | Goodrich et al. | Sep 2002 | B1 |
6454605 | Bassler et al. | Sep 2002 | B1 |
6456872 | Faisander | Sep 2002 | B1 |
6461179 | Sullivan et al. | Oct 2002 | B1 |
6487430 | Henderson et al. | Nov 2002 | B1 |
6494744 | Lee | Dec 2002 | B1 |
6514099 | Endo | Feb 2003 | B2 |
6517372 | Jones | Feb 2003 | B1 |
6531657 | Jones, Jr. et al. | Mar 2003 | B1 |
6533600 | Kashiyama et al. | Mar 2003 | B1 |
6540549 | Rupert | Apr 2003 | B2 |
6551117 | Poplawski et al. | Apr 2003 | B2 |
6553246 | Wenger | Apr 2003 | B1 |
6553250 | Rantala | Apr 2003 | B2 |
6558189 | Groebe et al. | May 2003 | B2 |
6561834 | Chen | May 2003 | B2 |
6564079 | Cory et al. | May 2003 | B1 |
6565388 | Van Woensel et al. | May 2003 | B1 |
6567680 | Swetlik et al. | May 2003 | B2 |
6575759 | Ollivier | Jun 2003 | B1 |
6575794 | Nakamura | Jun 2003 | B1 |
6582252 | Lin | Jun 2003 | B1 |
6589066 | Wu | Jul 2003 | B1 |
6592391 | Wu | Jul 2003 | B1 |
6592404 | Endo | Jul 2003 | B2 |
6604963 | Lin | Aug 2003 | B2 |
6607397 | Zhang et al. | Aug 2003 | B1 |
6609018 | Cory et al. | Aug 2003 | B2 |
6609833 | Miyachi et al. | Aug 2003 | B1 |
6611705 | Hopman et al. | Aug 2003 | B2 |
6612860 | Droesbeke | Sep 2003 | B2 |
6619976 | Huetter et al. | Sep 2003 | B2 |
6619989 | Yi | Sep 2003 | B1 |
6623312 | Merry et al. | Sep 2003 | B2 |
6636754 | Baura et al. | Oct 2003 | B1 |
6647286 | Kato et al. | Nov 2003 | B1 |
6648665 | Wu | Nov 2003 | B1 |
6648666 | Wu | Nov 2003 | B1 |
6654626 | Devlin et al. | Nov 2003 | B2 |
6655979 | Lee | Dec 2003 | B1 |
6659790 | Wu | Dec 2003 | B1 |
6663412 | Aramoto et al. | Dec 2003 | B2 |
6663419 | Vaden | Dec 2003 | B2 |
6663420 | Xiao | Dec 2003 | B1 |
6663570 | Matt et al. | Dec 2003 | B2 |
6669510 | Yamawaki et al. | Dec 2003 | B2 |
6688894 | Knox, Jr. et al. | Feb 2004 | B2 |
6688907 | Yamaoka et al. | Feb 2004 | B2 |
6702602 | Wu | Mar 2004 | B2 |
6702603 | Wu | Mar 2004 | B2 |
6702616 | Chang et al. | Mar 2004 | B1 |
6709284 | Avlonitis | Mar 2004 | B1 |
6716165 | Flanders et al. | Apr 2004 | B1 |
6722912 | Wu | Apr 2004 | B2 |
6736650 | Chen et al. | May 2004 | B1 |
6743053 | Wu | Jun 2004 | B2 |
6748797 | Breed et al. | Jun 2004 | B2 |
6751493 | Wenger | Jun 2004 | B2 |
6755689 | Zhang et al. | Jun 2004 | B2 |
6768921 | Organ et al. | Jul 2004 | B2 |
6773293 | Lee | Aug 2004 | B1 |
6780065 | Schwarz | Aug 2004 | B2 |
6786755 | Dambach et al. | Sep 2004 | B2 |
6786764 | Sivertsen | Sep 2004 | B2 |
D498535 | Genau et al. | Nov 2004 | S |
6816744 | Garfield et al. | Nov 2004 | B2 |
6832928 | Suzuki et al. | Dec 2004 | B2 |
6837734 | Ushlo et al. | Jan 2005 | B2 |
6847836 | Sujdak | Jan 2005 | B1 |
6848926 | Ling et al. | Feb 2005 | B2 |
6851969 | Archuletta | Feb 2005 | B2 |
6860750 | Wu | Mar 2005 | B1 |
6866535 | Uchida | Mar 2005 | B2 |
6881098 | Jeansonne et al. | Apr 2005 | B2 |
6891379 | Kelly et al. | May 2005 | B2 |
6913482 | Wu | Jul 2005 | B1 |
6939158 | Moffett et al. | Sep 2005 | B2 |
6939345 | Knight et al. | Sep 2005 | B2 |
6945796 | Bassler et al. | Sep 2005 | B2 |
6945807 | Wu | Sep 2005 | B1 |
6948973 | Hsu et al. | Sep 2005 | B1 |
6970731 | Jayaraman et al. | Nov 2005 | B1 |
6973341 | Watson | Dec 2005 | B2 |
6973343 | Wenger | Dec 2005 | B2 |
6980852 | Jersey-Willuhn et al. | Dec 2005 | B2 |
6984143 | Roese | Jan 2006 | B2 |
D516217 | Brown et al. | Feb 2006 | S |
6997733 | Peng | Feb 2006 | B2 |
7004787 | Milan | Feb 2006 | B2 |
7008255 | Wang | Mar 2006 | B1 |
7025618 | Fukuda | Apr 2006 | B2 |
7025628 | LaMeres et al. | Apr 2006 | B2 |
7029286 | Hallet et al. | Apr 2006 | B2 |
7033207 | Nimura | Apr 2006 | B2 |
7041918 | Wu | May 2006 | B1 |
7056134 | Martinet et al. | Jun 2006 | B2 |
7056141 | Moffett et al. | Jun 2006 | B2 |
7077711 | Moore | Jul 2006 | B1 |
7081008 | Tan | Jul 2006 | B2 |
7081026 | Schwarz | Jul 2006 | B2 |
7083480 | Silber | Aug 2006 | B2 |
7085598 | Sato | Aug 2006 | B2 |
7104801 | Brodnick et al. | Sep 2006 | B1 |
7110804 | Baumer et al. | Sep 2006 | B2 |
7117590 | Koenig et al. | Oct 2006 | B2 |
7118411 | Huang et al. | Oct 2006 | B2 |
7127279 | Finneran et al. | Oct 2006 | B2 |
7128600 | Osypka | Oct 2006 | B2 |
7134908 | Wu | Nov 2006 | B2 |
7137839 | Dilliner et al. | Nov 2006 | B2 |
7144268 | Koenig et al. | Dec 2006 | B2 |
7150655 | Mastrototaro et al. | Dec 2006 | B2 |
D535029 | McAtamney et al. | Jan 2007 | S |
7160136 | Zhang et al. | Jan 2007 | B2 |
7169107 | Jersey-Willuhn et al. | Jan 2007 | B2 |
7179111 | Van Der Mee et al. | Feb 2007 | B2 |
7179113 | Koenig et al. | Feb 2007 | B2 |
7182630 | Su | Feb 2007 | B1 |
7184820 | Jersey-Willuhn et al. | Feb 2007 | B2 |
7189097 | Benham | Mar 2007 | B2 |
7197357 | Istvan et al. | Mar 2007 | B2 |
7198502 | Koenig et al. | Apr 2007 | B2 |
7201599 | Holub | Apr 2007 | B2 |
7207825 | Le Gallic et al. | Apr 2007 | B2 |
7214107 | Powell et al. | May 2007 | B2 |
7236825 | Wang | Jun 2007 | B2 |
7252542 | Chen | Aug 2007 | B2 |
7252556 | Anbo et al. | Aug 2007 | B2 |
7252565 | Hunter | Aug 2007 | B2 |
7255609 | Epstein | Aug 2007 | B1 |
7258565 | Huang et al. | Aug 2007 | B2 |
7258566 | Koenig et al. | Aug 2007 | B2 |
7264510 | Koenig et al. | Sep 2007 | B2 |
7270568 | Osypka | Sep 2007 | B2 |
7270580 | Bradley et al. | Sep 2007 | B2 |
7272427 | Ristolainen | Sep 2007 | B2 |
7272428 | Hopman et al. | Sep 2007 | B2 |
7275951 | Shigeta et al. | Oct 2007 | B2 |
7281937 | Reed et al. | Oct 2007 | B2 |
7287998 | Masai | Oct 2007 | B2 |
7303430 | Butcher | Dec 2007 | B2 |
7318740 | Henry et al. | Jan 2008 | B1 |
7319895 | Klefstad-Sillinville et al. | Jan 2008 | B2 |
7322849 | Sutton | Jan 2008 | B2 |
7329139 | Benham | Feb 2008 | B2 |
7333850 | Marossero et al. | Feb 2008 | B2 |
7335053 | Avevor et al. | Feb 2008 | B2 |
7347710 | Ohtaka et al. | Mar 2008 | B2 |
7347826 | Karicherla et al. | Mar 2008 | B1 |
7359751 | Erickson et al. | Apr 2008 | B1 |
7361058 | Lien et al. | Apr 2008 | B1 |
7364440 | Gobron et al. | Apr 2008 | B2 |
7371102 | Sakamoto et al. | May 2008 | B2 |
7373196 | Ryu et al. | May 2008 | B2 |
7374448 | Jepsen et al. | May 2008 | B1 |
7381082 | Lai | Jun 2008 | B2 |
7390224 | Sodemann et al. | Jun 2008 | B2 |
7396246 | Okada et al. | Jul 2008 | B2 |
7399195 | Kim et al. | Jul 2008 | B2 |
7401946 | Laukhuf | Jul 2008 | B2 |
7402071 | Ohtaka et al. | Jul 2008 | B2 |
7413461 | Dawiedczyk et al. | Aug 2008 | B2 |
7413485 | Lappoehn | Aug 2008 | B2 |
7416440 | Homyk et al. | Aug 2008 | B2 |
7422437 | Lin et al. | Sep 2008 | B1 |
7422452 | Achter et al. | Sep 2008 | B2 |
7445512 | Lai | Nov 2008 | B1 |
7445522 | Burnes et al. | Nov 2008 | B2 |
7462074 | Devlin et al. | Dec 2008 | B1 |
7473141 | Liao | Jan 2009 | B2 |
7487738 | Hayashi | Feb 2009 | B2 |
7488187 | Wolf | Feb 2009 | B2 |
7494383 | Cohen et al. | Feb 2009 | B2 |
7497738 | Kuo | Mar 2009 | B2 |
7503807 | Martinet et al. | Mar 2009 | B2 |
7556535 | Liao | Jul 2009 | B2 |
7581992 | Liu et al. | Sep 2009 | B1 |
7585182 | Asante et al. | Sep 2009 | B2 |
7591673 | Chan et al. | Sep 2009 | B2 |
7604511 | Johnson | Oct 2009 | B1 |
7618377 | McAtamney et al. | Nov 2009 | B2 |
7632130 | Sami | Dec 2009 | B2 |
D609813 | Molden et al. | Feb 2010 | S |
7666028 | Meleck | Feb 2010 | B2 |
D629358 | Slippy et al. | Dec 2010 | S |
7950971 | Hobet et al. | May 2011 | B2 |
8038484 | Selvitelli et al. | Oct 2011 | B2 |
8152571 | Selvitelli et al. | Apr 2012 | B2 |
8251736 | McIntire et al. | Aug 2012 | B2 |
8255041 | Istvan et al. | Aug 2012 | B2 |
D675738 | Baumer et al. | Feb 2013 | S |
8408507 | Liu | Apr 2013 | B2 |
8408948 | Selvitelli et al. | Apr 2013 | B2 |
8414315 | Dekoski | Apr 2013 | B2 |
8455687 | Snow et al. | Jun 2013 | B2 |
D689614 | Browne et al. | Sep 2013 | S |
D699360 | Marzynski et al. | Feb 2014 | S |
8690611 | Selvitelli et al. | Apr 2014 | B2 |
8694080 | Farrior | Apr 2014 | B2 |
8795004 | Selvitelli et al. | Aug 2014 | B2 |
8897865 | Farrior | Nov 2014 | B2 |
D718867 | Schroderus | Dec 2014 | S |
9066093 | Hasegawa et al. | Jun 2015 | B2 |
9107594 | Selvitelli et al. | Aug 2015 | B2 |
9109948 | Pinguet et al. | Aug 2015 | B2 |
D737979 | Selvitelli et al. | Sep 2015 | S |
9408546 | Callahan | Aug 2016 | B2 |
9408547 | Zhou | Aug 2016 | B2 |
D771818 | Callahan | Nov 2016 | S |
20010053639 | Endo | Dec 2001 | A1 |
20020133069 | Roberts | Sep 2002 | A1 |
20020137997 | Mastrototaro et al. | Sep 2002 | A1 |
20020138011 | Rantala | Sep 2002 | A1 |
20020188216 | Kayyali et al. | Dec 2002 | A1 |
20030068914 | Merry et al. | Apr 2003 | A1 |
20030068918 | Christensson | Apr 2003 | A1 |
20040073127 | Istvan et al. | Apr 2004 | A1 |
20040127802 | Istvan et al. | Jul 2004 | A1 |
20040176674 | Nazeri | Sep 2004 | A1 |
20040203273 | Schwarz | Oct 2004 | A1 |
20050016825 | Endres et al. | Jan 2005 | A1 |
20050164551 | Wlos | Jul 2005 | A1 |
20050177052 | Istvan et al. | Aug 2005 | A1 |
20050203349 | Nanikashvili | Sep 2005 | A1 |
20060004273 | Lobodzinski | Jan 2006 | A1 |
20060073728 | Zaiken et al. | Apr 2006 | A1 |
20060110962 | Powell et al. | May 2006 | A1 |
20060286861 | Avevor et al. | Dec 2006 | A1 |
20070038057 | Nam et al. | Feb 2007 | A1 |
20070260133 | Meyer | Nov 2007 | A1 |
20080132106 | Burnes et al. | Jun 2008 | A1 |
20080132773 | Burnes et al. | Jun 2008 | A1 |
20080177168 | Callahan et al. | Jul 2008 | A1 |
20090099423 | Al-Aii et al. | Apr 2009 | A1 |
20090149731 | Selvitelli | Jun 2009 | A1 |
20090221153 | Santangelo et al. | Sep 2009 | A1 |
20090270709 | Copp et al. | Oct 2009 | A1 |
20100059722 | Copp-Howland et al. | Mar 2010 | A1 |
20110092833 | Farrior | Apr 2011 | A1 |
20110275252 | Selvitelli et al. | Nov 2011 | A1 |
20120196474 | Selvitelli et al. | Aug 2012 | A1 |
20130023750 | Callahan | Jan 2013 | A1 |
20130189881 | Selvitelli et al. | Jul 2013 | A1 |
20140170896 | Selvitelli et al. | Jun 2014 | A1 |
20140180148 | Coggins et al. | Jun 2014 | A1 |
20140243644 | Farrior | Aug 2014 | A1 |
20140275927 | Simpson | Sep 2014 | A1 |
20140303472 | Callahan | Oct 2014 | A1 |
20140309514 | Zhou | Oct 2014 | A1 |
20140322945 | Selvitelli et al. | Oct 2014 | A1 |
20160192851 | Selvitelli et al. | Jul 2016 | A1 |
Number | Date | Country |
---|---|---|
1853247 | Oct 2006 | CN |
101219047 | Jul 2008 | CN |
101491437 | Jul 2009 | CN |
101491438 | Jul 2009 | CN |
102185192 | Jun 2011 | CN |
102164538 | Aug 2011 | CN |
3523226 | Jan 1987 | DE |
9002539 | May 1990 | DE |
10225621 | Jan 2004 | DE |
102004032410 | Jan 2006 | DE |
0522693 | Jan 1993 | EP |
0766946 | Apr 1997 | EP |
0799628 | Oct 1997 | EP |
1050269 | Nov 2000 | EP |
1645224 | Apr 2006 | EP |
1932470 | Jun 2008 | EP |
2070474 | Jun 2009 | EP |
2339696 | Jun 2011 | EP |
162804 | May 1921 | GB |
H10248820 | Sep 1998 | JP |
2003010138 | Jan 2003 | JP |
2004282608 | Oct 2004 | JP |
WO 03047427 | Jun 2003 | WO |
WO 03474278 | Jun 2003 | WO |
WO 2008092098 | Jul 2008 | WO |
WO 2008092098 | Jul 2008 | WO |
WO 2013013370 | Jan 2013 | WO |
Entry |
---|
Notice of Allowance from U.S. Appl. No. 14/209,278, dated Feb. 27, 2017, 8 pp. |
A&D Company, Limited, “Vital Sensor Graphic Model;” No. TM-2560G/TM2564GTM2564GP/TM2564GP, Jan. 1, 2004; 62 Pages. |
Boos et al., “A New Lightweight Fetal Telemetry System”; Dec. 1995; Hewlett-Packard Journal; 12 Pages. |
Tyco Healthcare Kendall, “ECG Electrodes Where Quality Leads”; 2003; 8 Pages. |
Article 19 Amendment as filed dated Jul. 2, 2014 for App. No. PCT/US2014/019479; 10 pages. |
Chinese Office Action dated Jan. 12, 2015; with English Translation for Chinese App, No. 200180072455.9; 15 pages. |
Chinese Office Action dated Nov. 17, 2014 for Chinese Application No. 201310064924.3; 3 pages. |
Communication Pursuant to Rules 70(2) and 70a(2) EPC and reference to Rule 39(1) EPC dated May 26, 2015 for European Application No. 14197698.5; 2 pages. |
Decision to Grant dated Nov. 5, 2015 for Chinese Patent Application No. 201180072455.9; 6 pages. |
Divisional Application as filed on Mar. 1, 2013, for Chinese App. No. 200810191090.1; 37 pages. |
EP Notice Under Rule 161 dated Feb. 28, 2014, for EP App. No. 11869957.8; 3 pages. |
European Exam Report dated Mar. 11, 2014, for EP App. No. 12187209.7009542; 4 pages. |
European Exam Report dated Nov. 12, 2013, for EP App. No. 12187209.7009542; 6 pages. |
European Extended Search Report dated Nov. 18, 2014 for European Application No. 11869957.8; 9 pages. |
European Notice Responding to Search Report dated Nov. 11, 2013, for EP App. No. 12187209.7; 2 pages. |
European Office Action dated May 21, 2014, for EP App. No. 12187209.7009542; 5 pages. |
European Office Action dated Nov. 19, 2010, for EP App. No. 08171185.5; 1 page. |
European Search Report Corresponding to European Application No. EP 07253850, dated Dec. 21, 2007; 3 pages. |
European Search Report Corresponding to European Application No. EP 07253850, dated Dec. 21, 2007; 3 pp. |
European Search Report dated Apr. 17, 2015 for European Application No. 14197698.5; 7 pages. |
European Search Report dated May 23, 2014, for EP App. No. 14162076.5; 10 pages. |
Examination Report dated Jun. 24, 2013 for EP Application No. 08171185.5, filed Dec. 10, 2008; 4 pages. |
Extended Search Report dated Apr. 4, 2011, for EP App. No. 10013624.10; 14 pages. |
Extended Search Report dated Mar. 7, 2012, for EP App. No. 08171185.5 8 pages. |
Extended Search Report dated Oct. 8, 2013, for EP App. No. 12187209.7009542; 6 pages. |
First Office Action dated Jul. 26, 2011, for Chinese App. No. 200810191090.1; 6 pages. |
International Preliminary Report of Patentability dated Oct. 26, 2015 for PCT Application No. PCT/US2014/019479; 8 pages. |
International Preliminary Report on Patentability dated Sep. 24, 2015 for PCT Application No. PCT/US2014/027328; 12 pages. |
International Search Report and Written Opinion dated Sep. 9, 2014 for PCT Application No. PCT/US2014/027328; 16 pages. |
Letter and Chinese Office Action dated Jul. 1, 2014, for Chinese App. No. 2013100649128.3; 38 pages. |
Letter and Response to Office Action dated Apr. 23, 2013, for Mexican App. No. MX/a/2012/009542; 20 pages. |
Letter dated Apr. 2, 2012 and Office Action for Mexican App. No. MX/a/2008/015927; 3 pages. |
Letter dated Dec. 16, 2013 in response to Communication dated Jun. 24, 2013, for EP App. No. 08171185.5; 4 pages. |
Letter dated Dec. 20, 2012 enclosing Grant Notification dated Dec. 19, 2012, for Chinese App. No. 200810191090;14 pages. |
Letter dated Dec. 22, 2010 in response to EP Office Action Nov. 19, 2010 European Office Action for EP App. No. 08171185.5; 1 page. |
Letter dated Feb. 25, 2013 also enclosing Office Action for App. No. MX/a/2012/009542; 3 pages. |
Letter dated Feb. 5, 2014 Confirming receipt of Notice of Allowance. for Mexican App. No. MX/a/2012/009542;2 pages. |
Letter dated Jun. 10, 2014 Confirming receipt of Notice of Allowance for Mexican App. No. MX/a/2013/012636; 2 pages. |
Letter dated Jun. 26, 2012 and Regarding Notice of Allowance with allowed claims for Mexican App. No. MX/a/2008/015927; Filed on Dec. 11, 2008; 7 Pages. |
Letter dated May 11, 2012 enclosing Second Office Action dated Apr. 27, 2012, for Chinese App. No. 200810191090.1; 6 Pages. |
Letter dated May 15, 2012 and Response to Office Action for Mexican App. No. MX/a/2008/015927; Filed on Dec. 11, 2008; 9 Pages. |
Letter dated Oct. 4, 2012 and Divisional for EP App. No. 08171185.5; 39 pages. |
Letter dated Oct. 30, 2013 and Response to Office Action for Mexican App. No. MX/a/2012/009542; 5 pages. |
Letter dated Sep. 18, 2013 and Office Action for Mexican App. No. MX/a/2012/009542; 4 pages. |
Letter from CCPIT Patent and Trademark Law Office dated Jan. 2, 2015 for Chinese Application No. 201310064924.3, 7 pages. |
Letter from CCPIT Patent and Trademark Law Office dated Jan. 2, 2015 for Chinese Application No. 201310064924.3; 7 pages. |
Letter regarding Response to Office Action dated Nov. 22, 2011, for Chinese App. No. 200810191090.1; 9 pages. |
Notice of Allowance dated Apr. 23, 2015 for European Application No. 12187209.7; 39 pages. |
Notification of Entry into Examination Procedure dated Oct. 11, 2012, for Chinese App. No. 201010624971.50; 2 Pages. |
Notification of Response to Second Office Action dated Jun. 11, 2012, for Chinese App. No. 200810191090.1; 5 Pages. |
Notification to Grant dated May 25, 2015 for Chinese Application No. 20131006492.3; 5 pages. |
Office Action dated Aug. 6, 2014 for Chinese Application No. 201010624971.5; 17 pages. |
Office Action dated Dec. 17, 2015 for U.S. Appl. No. 14/209,278; 6 pages. |
Office Action dated Jul. 23, 2015 for Chinese Application No. 201180072455.9; 7 pages. |
Office Action dated Jun. 26, 2014 for Australian Application No.-2010235901; 4 pages. |
Office Action dated May 29, 2015 for Canadian Application No. 2841601; 5 pages. |
Office Action dated May 4, 2015 for Canadian Application No. 2,646,037; 4 pages. |
Partial Search Report dated Jun. 5, 2014 for Application No. PCT/US2014/027328; 6 pages. |
Receipt of First Office Action dated Nov. 28, 2013, for Chinese App. No. 201010624971.50; 136 Pages. |
Response dated Jan. 27, 2014 to Extended Search Report dated Oct. 8, 2013, for EP App. No. 12187209.7009542; 16 pages. |
Response dated Nov. 2, 2011 to Communication dated May 10, 2011 for EP App. No. 10013624.10; 5 pages. |
Response filed on Feb. 6, 2015; for Office Action dated Sep. 10, 2014; for U.S. Appl. No. 14/324,380; 8 pages. |
Response to Chinese Office Action dated May 4, 2011, for Chinese App. No. 201010624971.50 21 pages. |
Response to Chinese Office Action filed Oct. 24, 2014 with English translation for Chinese Application No. 201310064924.3; 27 pages. |
Response to Communication dated Mar. 17, 2014 for EP App. No. 12187209.7009542; 14 pages. |
Response to Exam Report dated Jun. 24, 2014 for EP App. No. 12187209.7; 8 pages. |
Response to Examiner's Report filed Nov. 30, 2015 for Canadian Application No. 2,841,601; 11 pages. |
Response to Examiner's Report filed Nov. 4, 2015 for Canadian Application No. 2,646,037; 22 pages. |
Response to Office Action dated Apr. 14, 2014, for Chinese App. No. 201010624971.50; 34 Pages. |
Response to Office Action dated Dec. 12, 2011, for Chinese App. No. 200810191090.11;8 pages. |
Response to Office Action dated Oct. 3, 2012 for EP App. No. 08171185.5; 2 pages. |
Response to office action filed Aug. 7, 2015 for European Application No. 14197698.5; 27 pages. |
Response to office action filed Jun. 1, 2015 for European Application No. 11869957; 10 pages. |
Response to Office Action filed Sep. 30, 2015 for Chinese Application No. 201180072455.9; 3 pages. |
Response to Office Action with English translation filed Feb. 2, 2015 for Chinese Application No. 201310064924.3; 23 pages. |
Response to Office action with English translation filed May 27, 2015 for Chinese Application No. 201180072455.9; 15 pages. |
Response to Written Opinion and Claims Filed on Jun. 11, 2014, for EP App. No. 11869957.8; 6 pages. |
Search Report and Written Opinion dated Apr. 12, 2012, for App. No. PCT/CN2011/077506; 14 pages. |
Search Report dated Jun. 4, 2014, for App. No. PCT/US2014/019479; 10 pages. |
Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPO dated Nov. 2, 2015 for European Application No. 08171185.5; 3 pages. |
Voluntary Amendment with English claims dated Jul. 15, 2014 for Application No. 201180072455.9; 7 pages. |
Prosecution History from U.S. Appl. No. 13/987,326, dated Jun. 9, 2014 through Jun. 22, 2016; 58 pp. |
U.S. Appl. No. 29/528,574, by David Selvitelli, filed May 29, 2015, 3 pp. |
U.S. Appl. No. 14/041,484, by David Selvitelli, filed Sep. 30, 2013, 20 pp. |
U.S. Appl. No. 14/825,206, by David Selvitelli, filed Aug. 13, 2015, 20 pp. |
Notice of Allowance from U.S. Appl. No. 29/528,574, dated Jan. 25, 2017; 8 pp. |
Prosecution History from U.S. Appl. No. 14/160,798, dated Apr. 10, 2015 through Apr. 8, 2016; 44 pp. |
Prosecution History from U.S. Appl. No. 14/041,484, dated Sep. 30, 2013 through Mar. 27, 2014; 23 pp. |
Prosecution History from U.S. Appl. No. 29/498,717, dated Aug. 14, 2015 through May 24, 2016; 41 pp. |
Prosecution History from U.S. Appl. No. 14/324,380, dated Jul. 7, 2014 through Jun. 25, 2015; 57 pp. |
Prosecution History from U.S. Appl. No. 13/785,713, dated Mar. 5, 2013 through Feb. 14, 2014; 39 pp. |
Prosecution History from U.S. Appl. No. 14/825,206, dated Mar. 17, 2016 through Jul. 27, 2016; 24 pp. |
Prosecution History from U.S. Appl. No. 12/330,550, dated Nov. 30, 2010 through Jul. 8, 2011; 35 pp. |
Prosecution History from U.S. Appl. No. 13/182,656, dated Jul. 14, 2011 through Dec. 5, 2011; 32 pp. |
Prosecution History from U.S. Appl. No. 13/443,096, dated Apr. 10, 2012 through Feb. 13, 2013; 44 pp. |
Prosecution History from U.S. Appl. No. 12/876,316, dated Jul. 20, 2012 through May 28, 2013; 74 pp. |
Prosecution History from U.S. Appl. No. 14/041,471, dated Sep. 30, 2013 through May 23, 2014, 44 pp. |
Prosecution History from U.S. Appl. No. 14/195,140, dated May 19, 2014 through Jul. 25, 2014; 87 pp. |
Prosecution History from U.S. Appl. No. 29/486,095, dated Jul. 15, 2014 through May 15, 2015; 57 pp. |
Prosecution History from U.S. Appl. No. 15/230,935, dated Aug. 9, 2016 through Jan. 23, 2017; 24 pp. |
Prosecution History from U.S. Appl. No. 14/209,278, dated Dec. 17, 2015 through May 13, 2016; 19 pp. |
Notice of Allowance from U.S. Appl. No. 15/230,935 dated Apr. 21, 2017, 6 pp. |
Number | Date | Country | |
---|---|---|---|
20170065197 A1 | Mar 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13987326 | Mar 2013 | US |
Child | 15218339 | US |